Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Pharmaceutical

Idorsia

Idorsia's headquarters in Allschwil, Switzerland

The Cherry Hill office focuses on U.S. medical affairs, compliance, sales training, and business development strategies.

Cherry Hill

The London office focuses on sales, marketing, and brand management for the UK market.

��

People (6)

Jobs (0)

Other offices

��������

People (6)

Jobs (0)

Other offices

��